ISRG

Intuitive Surgical's ISRG raised its full-year outlook on the first-quarter earnings call, primarily supported by a broadly diversified procedure growth profile. The management increased its 2026 da Vinci procedure growth guidance to 13.5-15.5% from 13-15%, reflecting confidence in sustained adoption trends.

Intuitive Surgical (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Nvidia makes the computer chips that power artificial intelligence. The chipmaker is doing well right now, but competition is fierce, and technology is changing rapidly.

Intuitive Surgical (NASDAQ:ISRG | ISRG Price Prediction) is positioned for multi-decade compounding because it sits at the center of an aging-world healthcare megatrend with a razor-and-blade business model that compounds quietly whether the broader market is euphoric or fearful.

Rising P/E ratios can signal confidence and momentum. Discover 5 stocks backed by strong earnings growth and upside potential.

Intuitive Surgical stands out from other large cap healthcare companies as a high-growth company and a pure play in very attractive segment of the industry. The seemingly elevated earnings multiple is a cause of concern to many, but it is justified once we account for the overall quality of the business model. International and procedure expansion of ISRG platforms make the highly profitable business model worth considering even at nearly 50 times current earnings.

Intuitive Surgical has become a more attractive opportunity after a 28% stock decline, prompting an upgrade from Hold to Buy. ISRG operates in a high-growth surgical robotics market, which could nearly triple by 2033, supporting long-term bullishness. Despite a premium valuation, ISRG's consistent top and bottom-line growth and management execution justify its price.

ISRG placed 431 da Vinci systems in Q1 2026, but rising trade-ins and leasing growth raise questions about whether demand is structural or upgrade-driven.

Wall Street rallied toward record highs Monday as President Donald Trump declared the Strait of Hormuz reopened and oil prices plunged, yet a cluster of the market's biggest names are still trading well below their pre-war levels.

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?